Q’Apel Medical has announced the appointment of Jodie Fam as its new chief executive officer (CEO). With more than two decades in the medical device industry, Fam has held executive leadership positions at multiple medical device companies, including public and several venture-backed startups, “building a solid track record of experience in execution and commercial expansion” during her industry tenure, as noted in a Q’Apel press release.
Fam succeeds R King Nelson, who retires after leading the company for the past five years and will continue to serve on Q’Apel’s board of directors.
Q’Apel claims to be “revolutionising” neurovascular interventions with an innovative product portfolio that includes the Walrus balloon guide catheter, Armadillo neurovascular access system, and Hippo advanced aspiration system featuring the Cheetah delivery tool.
“On behalf of the board, we thank King for his leadership. He has built a strong team and delivered significant growth for the company,” said Chris Martin, chairman of Q’Apel’s board. “We are pleased to have Jodie assume this role and are confident that, with her at the helm, Q’Apel is positioned for an incredibly bright future.”
“Jodie has been an integral part of Q’Apel’s leadership team for the past three years as chief marketing officer and general manager of international. We are thrilled to have her lead the organisation going forward,” commented Nelson. “With a deep industry knowledge and expertise bringing disruptive technologies to market, Jodie is ideally suited to spearhead this next phase of the company’s growth. I am confident that, under her leadership, the organisation will deliver on its strategic objectives and drive commercial value.”
Most recently, Fam served as Q’Apel’s chief marketing officer and general manager for the company’s international business. Prior to joining Q’Apel, she served as the CEO of AblaCare (now May Health), and held senior management positions at Route 92 Medical, Medina Medical (acquired by Medtronic), CardioKinetix and Concentric Medical (acquired by Stryker). Earlier in her career, Fam held senior clinical, sales and marketing positions with Guidant Corporation, Johnson & Johnson and Mallinckrodt Medical.
“Since its inception, Q’Apel has been known for approaching clinical challenges differently. It is at the core of all we do and one of the most differentiating aspects of our organisation,” stated Fam. “I am thrilled and honoured to serve as the company’s next CEO and look forward to working with our world-class team. Together, we will build upon our strong foundation to uniquely and purposefully position Q’Apel for a new era of growth, stability and success.”
